GE HealthCare has widened its collaboration with RadNet subsidiary DeepHealth, advancing efforts to accelerate the development and deployment of AI mammography solutions. The announcement aligns with the Society of Breast Imaging (SBI) Annual Symposium taking place in Seattle, underscoring the companies’ continued focus on innovation in breast cancer screening technologies.
The partnership, initially established in 2024, was designed to support the integration of artificial intelligence across imaging workflows. At its core, the initiative combines DeepHealth’s AI-driven breast cancer screening tools with GE HealthCare’s Senographe Pristina mammography platform. Since then, both companies have progressively expanded the scope of their collaboration, including plans to extend their offerings beyond the U.S. market and enhance the capabilities of their integrated solutions.
Recent developments center on DeepHealth’s Breast Suite, a cloud-based platform comprising modular and interoperable applications tailored for breast imaging environments. When integrated with GE HealthCare’s Pristina Via system, the suite is positioned to enable scalable and efficient screening programs. The updated Breast Suite introduces additional tools designed for compatibility with GE HealthCare systems, including ProFound Pro, which combines Cancer Detection capabilities with Automated Density Assessment. These features provide automated lesion localization, consistent density classification, and improved diagnostic support. The Safeguard Review functionality further enhances workflows by identifying complex cases that may require secondary evaluation.
Commenting on the collaboration, Jyoti Gupta, president and CEO, Women’s Health and X-ray at GE HealthCare, said:
“At GE HealthCare, we’re advancing women’s health through precision care built around the unique needs of women and enhanced by the power of AI. By integrating Breast Suite AI with our Pristina Via mammography system, we’re helping clinicians detect breast cancer early with greater confidence. These innovations move us closer towards truly personalized prevention and care for women.”
Dr. Niccolo Stefani, business leader, Population Health & Clinical AI, DeepHealth, added:
“At DeepHealth, we are committed to bringing the next era of AI-powered health informatics to help stage shift disease. Through our expanded collaboration with GE HealthCare, we are bringing the power of our new Breast Suite to providers around the world to enable early cancer detection, deeper clinical insights, and more confident decisions.”
The expanded initiative reflects a continued push toward improving clinical accuracy, workflow efficiency, and global accessibility of AI mammography technologies, reinforcing both companies’ commitment to advancing women’s health through data-driven imaging solutions.
